We’re delighted to announce the launch of the Sandwich Economic Impact Report, which outlines the economic and social footprint of our Sandwich site.
The impact of Pfizer's Sandwich site in the UK
Commissioned by Pfizer and produced by consultancy firm Public First, the report demonstrates that Pfizer and our Sandwich site remain a significant contributor to the overall prosperity and wellbeing of not just the local area but beyond to wider Kent and the whole of the UK.
The key findings are:
Pfizer’s Sandwich site plays a crucial role in the development of life-saving medicines
- Since 2014 the company has spent over £1.2 billion supporting UK R&D (primarily at Sandwich) and around 85% of all Pfizer’s small molecule products pass through the site on their journey to market.
Pfizer Sandwich impacts millions of patients globally
- The site contributes to ensuring millions of patients in over 100 countries continue to receive our medicines through our licence maintenance activities
The site is a key anchor employer for the local area, boosting its economy and culture
- We’ve estimated that for every Pfizer job at Sandwich, an additional two are created or supported across the economy – 2,378 jobs in total – and that colleagues at the site contribute around £10 million a year to the Kent economy through spending with local businesses and charities.
Colleagues at the site are highly productive and are overwhelmingly proud of their work
- The 754 colleagues in Sandwich generate an estimated £267 million in gross added value (GVA) for the UK economy – far above the UK average – and, of those answering our colleague survey at the site, 96% agreed with the statement that they were proud to work for Pfizer at Sandwich and 83% thought that the things they did in their job were highly worthwhile.
Sandwich is helping to train and encourage the next generation of scientists
- The site has around 30 graduate placements and 10 apprenticeships at any one time and in 2018-19 around 17,000 students and school children were involved in programmes run directly by Pfizer colleagues in the region, such as Community Lab and Lab in a Box.
PP-PFE-GBR-4217 / November 2021